Harvard Bioscience, Inc. - Common Stock (HBIO)
Frequently Asked Questions About Harvard Bioscience, Inc. - Common Stock (HBIO)
Does Harvard Bioscience, Inc. engage in corporate social responsibility?
Yes, Harvard Bioscience, Inc. is engaged in corporate social responsibility initiatives aimed at enriching the scientific community and addressing societal challenges. The company supports education in science and technology, engages in partnerships with academic institutions, and participates in community outreach programs. Through these efforts, Harvard Bioscience aims to promote scientific advancement while giving back to the community.
How can investors find more information about Harvard Bioscience, Inc.?
Investors seeking more information about Harvard Bioscience, Inc. can visit the company's investor relations page on their official website, where they can find financial statements, press releases, and stock information. Additionally, financial news platforms, stock analysis websites, and regulatory filings with the SEC can provide valuable insights into the company’s performance, growth prospects, and strategic initiatives.
How does Harvard Bioscience, Inc. ensure product quality?
Product quality at Harvard Bioscience, Inc. is ensured through rigorous testing and adherence to industry standards throughout the manufacturing process. The company implements quality management systems and conducts regular audits to maintain compliance with regulatory demands and ensure that products meet the performance expectations of researchers. Continuous feedback from customers also plays a crucial role in improving product quality and functionality.
How does Harvard Bioscience, Inc. support customer service?
Harvard Bioscience, Inc. places a strong emphasis on customer service to ensure that researchers receive the support they need for optimal use of their products. The company provides comprehensive technical support, training, and resources to assist customers in troubleshooting, applications, and product usage. Their dedicated customer service team is available to help address inquiries and ensure a positive experience with their products.
How has Harvard Bioscience, Inc.'s stock performed recently?
The performance of Harvard Bioscience, Inc.'s stock can vary based on market conditions, investor sentiment, and company-specific developments. For the most accurate and up-to-date information regarding its stock performance, including current price trends and historical performance data, it is advisable to consult financial news platforms, stock market analysis tools, or the company's investor relations page.
Is Harvard Bioscience, Inc. a publicly traded company?
Yes, Harvard Bioscience, Inc. is a publicly traded company. It is listed on the NASDAQ stock exchange under the ticker symbol 'HBIO.' Being publicly traded allows the company to access capital from public investors while providing transparency in its financial performance and operations to shareholders and the market at large.
What are the future plans for Harvard Bioscience, Inc.?
The future plans for Harvard Bioscience, Inc. include a continued focus on innovation and expanding their product portfolio to meet the changing needs of life science researchers. The company is committed to investing in research and development, pursuing strategic partnerships and acquisitions, and exploring opportunities in emerging markets. This comprehensive approach aims to strengthen their position as a leader in the life sciences sector.
What are the primary challenges faced by Harvard Bioscience, Inc.?
Harvard Bioscience, Inc. faces several challenges common to the life sciences industry, including rapid technological advancements, pricing pressures, and increasing competition. Additionally, compliance with regulatory requirements and adapting to changing market demands can pose challenges. The company proactively addresses these issues through strategic planning, innovation, and maintaining flexibility in its operations.
What does Harvard Bioscience, Inc. do?
Harvard Bioscience, Inc. is a global developer, manufacturer, and supplier of a variety of specialized tools and equipment for the life science research community. The company focuses on producing a range of innovative products designed to facilitate research in areas such as physiology, pharmacology, and molecular biology. Their product offerings include scientific instruments, consumables, and accessories that cater to researchers working in laboratories, helping to advance scientific discovery and improve the efficacy of research.
What industries does Harvard Bioscience, Inc. serve?
Harvard Bioscience, Inc. serves the life sciences industry, particularly focusing on markets related to biomedical research and laboratory processes. Their products are used by researchers in academic institutions, biotechnology firms, pharmaceutical companies, and government laboratories. These researchers utilize Harvard Bioscience’s innovative solutions to conduct experiments, develop new drugs, and explore biological systems, thereby driving advancements in healthcare and scientific knowledge.
What is Harvard Bioscience, Inc.'s mission statement?
Harvard Bioscience, Inc. aims to provide advanced and innovative solutions that empower scientists and researchers to achieve scientific breakthroughs. The company's mission emphasizes quality, reliability, and commitment to customer satisfaction, reflecting its goal of supporting life science research that translates into improved health outcomes and follows a science-driven approach to product development.
What is the company's environmental policy?
Harvard Bioscience, Inc. recognizes the importance of environmental sustainability and strives to minimize its ecological footprint. The company’s environmental policy includes measures to reduce waste, conserve energy, and promote responsible sourcing and manufacturing practices. By focusing on sustainability, Harvard Bioscience aims to contribute positively to both the scientific community and the environment while delivering high-quality products.
What is the company’s approach to research and development?
Harvard Bioscience, Inc. is committed to continuous research and development to enhance its product offerings and address the evolving needs of the life sciences market. The company invests in R&D initiatives aimed at innovation, designing new products, and improving existing technologies. Collaboration with academic institutions and industry partners further enriches this effort, allowing for the integration of cutting-edge research with practical applications in laboratory settings.
What markets does Harvard Bioscience, Inc. operate in internationally?
Harvard Bioscience, Inc. operates in a variety of international markets, exporting its products to regions including Europe, Asia, and the Americas. By reaching global customers, the company takes advantage of opportunities in growing markets and adapts its product offerings to meet diverse scientific needs worldwide. This international presence reinforces its commitment to serving life science researchers on a global scale.
What recent acquisitions has Harvard Bioscience, Inc. made?
In recent years, Harvard Bioscience, Inc. has strategically acquired a number of companies to broaden its product portfolio and enhance its technological capabilities. These acquisitions are aimed at expanding its reach within the life sciences market and enhancing its ability to offer a diverse range of innovative solutions. Specific details about recent acquisitions can be found in the company's press releases and financial reports.
What types of products does Harvard Bioscience, Inc. manufacture?
Harvard Bioscience, Inc. manufactures a diverse range of products that include scientific instruments for electrophysiology, micro-manipulation, and drug testing, as well as consumables such as laboratory animal care products, surgical tools, and cell culture systems. Additionally, the company provides software solutions to facilitate data collection and analysis in research settings. Their comprehensive portfolio addresses various needs within the life sciences research community.
When was Harvard Bioscience, Inc. founded?
Harvard Bioscience, Inc. was founded in 1901. Initially a small company offering laboratory instruments, it has since evolved into a prominent player in the life sciences sector. Over the years, Harvard Bioscience has grown through a combination of organic growth and strategic acquisitions, continuously expanding its product portfolio and technological capabilities to serve a diverse range of scientific researchers worldwide.
Where is Harvard Bioscience, Inc. headquartered?
Harvard Bioscience, Inc. is headquartered in Holliston, Massachusetts, USA. This location serves as the central hub for the company’s operations, including product development, manufacturing, and administrative functions. Being based in Massachusetts, a region known for its rich academic and research institutions, enables Harvard Bioscience to maintain close ties with leading universities and research facilities, fostering collaboration and innovation.
Who are Harvard Bioscience, Inc.'s competitors?
Harvard Bioscience, Inc. competes with a variety of companies in the life sciences instrumentation market, including Thermo Fisher Scientific, Agilent Technologies, and PerkinElmer. These competitors also develop and supply scientific tools and equipment aimed at enhancing laboratory research. The competitive landscape is characterized by rapid technological advancements, leading to continued innovation and improvements in products and services within the life sciences industry.
What is the current price of Harvard Bioscience, Inc. - Common Stock?
The current price of Harvard Bioscience, Inc. - Common Stock is 6.130
When was Harvard Bioscience, Inc. - Common Stock last traded?
The last trade of Harvard Bioscience, Inc. - Common Stock was at 4:00 pm EDT on April 17th, 2026
What is the market capitalization of Harvard Bioscience, Inc. - Common Stock?
The market capitalization of Harvard Bioscience, Inc. - Common Stock is 261.68M
How many shares of Harvard Bioscience, Inc. - Common Stock are outstanding?
Harvard Bioscience, Inc. - Common Stock has 42.69M shares outstanding.